Ipilimumab

Form: Injection

Strength: 5 mg/1 mL (vial)

Reference Brands: Yervoy® (EU & US)

Category: Oncology Cancer Care

Ipilimumab (brand name Yervoy®) is a monoclonal antibody used in oncology as an immune checkpoint inhibitor. By blocking the CTLA-4 receptor on T-cells, Ipilimumab enhances the body’s immune response, allowing T-cells to more effectively recognize and attack cancer cells. It is primarily used in the treatment of melanoma, renal cell carcinoma (RCC), and non-small cell lung cancer (NSCLC), among other cancers. Ipilimumab is often combined with nivolumab (Opdivo®) for improved efficacy, especially in metastatic melanoma and other advanced cancers. It is administered as an intravenous (IV) infusion, available in a 5 mg/1 mL vial.